Thursday, April 15, 2021
Home News Reports Pfizer vaccine trials show a 90% success rate, ultra-cold storage requirements may haunt distribution

Pfizer vaccine trials show a 90% success rate, ultra-cold storage requirements may haunt distribution

One of the main issues that will make the distribution difficult is that the vaccine requires minus 70 degrees (-94 F) or below. Other vaccines under development do not have such low-temperature requirement and can be stored at 2 to 5 degrees celsius.

The Covid-19 vaccine under development by Pfizer Inc and BioNTech is reportedly showing very promising results in the initial trials. On Monday, the company said that it could be dubbed as a significant victory in the war against the virus that has killed over a million people and crippled the world economy.

The experts are welcoming the first successful interim data from a large-scale clinical test. However, the vaccine’s mass distribution will be a significant issue due to several roadblocks, including storage requirements and regulatory approvals.

Pfizer expecting regulatory approval by December

Pfizer and German partner BioNTech said they had not found any serious safety concerns yet. They expect to get emergency use authorization this month in the US, which will raise a chance of regulatory approval in December. In case the company receives the required permissions, they can roll out 50 million doses this year, which will protect 25 million people. In 2021, the company expects to produce 1.3 billion doses.

Pfizer Chief Executive Albert Bourla said data milestone comes with “infection rates setting new records, hospitals nearing over-capacity and economies struggling to reopen.” The experts are waiting to check the full trial data, but the initial results are encouraging. Peter Horby, professor of emerging infectious diseases at the University of Oxford, said, “This news made me smile from ear to ear. It is a relief to see such positive results on this vaccine and bodes well for COVID-19 vaccines in general.” U.S. infectious diseases expert Dr. Anthony Fauci told CNN that it is extraordinary that the vaccine is more than 90% effective.

The company is seeking US emergency use authorization for people between the 16 to 85 age group. A follow-up safety data of two months is required for the said permission as it is necessary to assure no side effects crop up. The said data should be available by the third week of November. According to the U.S. Health and Human Services Secretary Alex Azar may take several weeks for the regulators to process data before approving the vaccine.

The vaccine may not be available in the pharmacy next door

One of the main issues that will make the distribution difficult is that the vaccine requires minus 70 degrees (-94 F) or below. Amesh Adalja, the senior scholar at Johns Hopkins Center for Health Security, said, “The cold chain is going to be one of the most challenging aspects of the delivery of this vaccination.” Even in the big cities, the hospitals do not have such storage facilities where storing vaccines at ultra-low temperature is possible.

Even one of the US’s best hospitals, the Mayo Clinic in Rochester, Minnesota, said they could not store the vaccine. Dr. Gregory Poland, a virologist and vaccine researcher with the Mayo Clinic, said, “We’re talking about a vaccine that needs storage at minus 70 or 80. That’s a tremendous logistical issue not only in the U.S. but outside the Western world.”

Pfizer spokeswoman Kim Bencker said they are working with the US government and state officials to ensure the smooth distribution of the vaccine worldwide from its distribution centres in the US, Germany, and Belgium.

The vaccine will spoil in five days of standard refrigeration

In general, the refrigeration system at most of the storage facilities across the globe store medicines at 2-5 degrees above the freezing point. In such a situation, the vaccine will be viable only for five days. The company is finding ways to store it for up to two weeks. However, if the vaccine is stored under minus 70 degrees, it can remain usable for up to six months.

Other vaccines do not need such low-temperature storage

The vaccine of Moderna Inc works on similar technology as Pfizer, but it does not need such low-temperature storage. Vaccines by  Johnson & Johnson and Novavax Inc can be stored at 2-8 degrees, which is in the normal range of storage facilities’ refrigeration units.

While the hospitals are working on upgrading their storage facilities in the US, it will be far more challenging to distribute the vaccination for the developing countries and rural areas.

  Support Us  

Whether NDTV or 'The Wire', they never have to worry about funds. In name of saving democracy, they get money from various sources. We need your support to fight them. Please contribute whatever you can afford

OpIndia Staffhttps://www.opindia.com
Staff reporter at OpIndia

Related Articles

Trending now

Hindu leader in Panipat explains why he thought it is necessary to come out in streets in support of Yati Narsinghanand Saraswati

A Muslim mob came face to face with Hindu organisations who carried out a sit-in vigil in support of Yati Narsinghanand Saraswati

Amdavad Municipal Corporation introduces ‘drive through’ RTPCR testing as COVID-19 cases surge in the state

First ever drive-through RTPCR testing centre opened in Ahmedabad, Gujarat as the state battles Chinese coronavirus

UP govt ramps up measures to fight the resurgent COVID-19 outbreak, airlifts 25,000 doses of Remdesivir using govt plane from Gujarat

The Uttar Pradesh government is working on a war-footing to blunt the second wave of the COVID-19 outbreak

One more video of a mob calling for beheading Yati Narsimhanand Saraswati for ‘insulting Prophet Muhammad’ goes viral

Muslims across the country are demanding the beheading of Yati Narsimhanand Saraswati after his comments criticising Islam

Tours and travels operators in Mumbai issuing fake COVID-19 negative reports for Rs 300: Report reveals

As people in Mumbai rush to get out of Maharashtra amidst worsening coronavirus outbreak, travel agents are arranging bogus COVID-negative reports for Rs 300 to Rs 500 to enable their exit.

Maha COVID-19 crisis: Hospital beds and ventilators running short, scarcity in oxygen and Remdesivir supply, and inordinate delays in testing

Maharashtra is in a midst of a resurgent coronavirus outbreak as the state has reported over 60,212 fresh COVID-19 cases on Tuesday

Recently Popular

Pfizer wanted Brazil, Argentina to put military bases, Federal reserve as collateral: Why India kept Pfizer away and how the usual suspects are wrong

Pfizer has been accused of countries in Latin America of pledging their sovereign assets, military bases and financial reserves to protect itself from any adverse fallout of the vaccine

OpIndia Exclusive: Tata Communications suffers data leak, hackers claim to have sold access to company’s servers, over 50GB data still up for sale

As per two posts by hackers on a hackers' forum, they have gained access to Tata Communications servers and sold them.

What happened in Chhabra after Hindu man was stabbed by Muslim men: Call for peace, attack on a Hindu the next day and more

On April 12, the administration extended curfew for one more day at Chhabra, Baran district in Rajasthan after the communal riot

Attempts to draw false equivalence between the Kumbh Mela and Tablighi Jamaat congregation do not make sense: Here’s why

Attempts are being made to draw false equivalences between the Kumbh Mela and the Tablighi Jamaat congregation last year.

It’s a lung… it’s a burnt toast… it’s a duck pic… No! It’s a painting by Mamata Banerjee

Mamata Banerjee did not appear in any election rallies or gave any statement regarding the ongoing Assembly elections in West Bengal after Election Commission banned her from campaigning for 24 hours

Mayor Sadiq Khan vows to bring the Indian Premier League to London to boost his reelection chances: Details

London mayor Sadiq Khan promises to bring the Indian Premier League to the British capital as part of his reelection campaign.
- Advertisement -

 

Connect with us

254,077FansLike
529,110FollowersFollow
24,200SubscribersSubscribe